TABLE 2.
The prognostic value of single CpG of FRAS1 and FREM2 in KIRC by MethSurv (p < 0.05).
Gene | Relation to island | Genomic region | CpG site | Best_split | HR | CI | LR test p value |
---|---|---|---|---|---|---|---|
FRAS1 | |||||||
Open_Sea | Body | cg20948271 | q25 | 0.41 | (0.276; 0.611) | 2.95E-05 | |
Open_Sea | Body | cg17512,802 | mean | 2.544 | (1.65; 3.922) | 7.49E-06 | |
Island | Body | cg02494368 | mean | 0.441 | (0.286; 0.681) | 0.000104156 | |
Open_Sea | Body | cg14091154 | q25 | 0.47 | (0.314; 0.704) | 0.000486185 | |
Open_Sea | Body | cg04091555 | q25 | 0.51 | (0.341; 0.764) | 0.001728597 | |
N_Shore | Body | cg03877364 | median | 1.856 | (1.253; 2.75) | 0.001735773 | |
Island | TSS200 | cg11073571 | q75 | 0.423 | (0.244; 0.733) | 0.000734126 | |
Island | TSS200 | cg11940149 | q75 | 0.428 | (0.247; 0.741) | 0.000872463 | |
Island | Body | cg16678047 | q25 | 2.328 | (1.341; 4.041) | 0.000980456 | |
Island | Body | cg04366385 | q75 | 0.435 | (0.251; 0.752) | 0.001079704 | |
FREM2 | |||||||
Open_Sea | Body | cg26881651 | mean | 0.489 | (0.333; 0.719) | 0.000342 | |
Open_Sea | 3′UTR | cg18595137 | q25 | 2.426 | (1.38; 4.265) | 0.000642 | |
N_Shore | TSS1500 | cg05542757 | q75 | 1.877 | (1.257; 2.804) | 0.003037 | |
Island | 1stExon | cg12844784 | q25 | 2.383 | (1.306; 4.348) | 0.001604 | |
Open_Sea | Body | cg03623599 | q25 | 1.926 | (1.171; 3.17) | 0.00591 | |
N_Shore | TSS200 | cg21662160 | q75 | 1.607 | (1.067; 2.419) | 0.02758 | |
Island | 1stExon | cg26063106 | q75 | 1.597 | (1.063; 2.398) | 0.028575 | |
N_Shore | TSS1500 | cg25822402 | q75 | 0.575 | (0.352; 0.941) | 0.020161 | |
S_Shelf | 1stExon | cg19582,128 | mean | 0.647 | (0.436; 0.96) | 0.034219 | |
Island | 1stExon; 5′UTR | cg24087887 | q25 | 1.668 | (1.024; 2.715) | 0.030612 |
Abbreviations: KIRC, kidney renal clear cell carcinoma; HR, hazard ratio; LR, test, likelihoodratio test.